top of page

Respira Health

23.png
15_edited.jpg
16_edited.jpg

STARTED: 2025 April

Rowan Lund

Co-founder

SEED GRANT: $110,000

Oli Munns

Co-founder

24.png

Closing the treatment gap for Chronic Obstructive Pulmonary Disease (COPD), the world's fourth deadliest disease.

DESCRIPTION OF THE INTERVENTION

Chronic Obstructive Pulmonary Disease (COPD) is the fourth leading cause of death worldwide. It’s a degenerative lung condition, primarily caused by smoking and air pollution, which leads to respiratory and heart failure. It kills more than 3 million people every year and 90% of these deaths are in low- and middle-income countries.


While pulmonary rehabilitation (PR) is a proven, cost-effective treatment, access in LMICs is severely limited due to healthcare workforce shortages and logistical barriers. Digital PR offers a breakthrough: the same life-extending care, accessible anytime, anywhere.


During the first year, Respira Health will be building and testing their digital solution. Their focus is on evaluating their current assumptions and building a model that they can scale in the following years.


Charity Entrepreneurship (CE) is a registered charity in England and Wales (Charity Number 1195850). CE supports its incubated charities through a fiscal sponsorship with Players Philanthropy Fund (Federal Tax ID: 27-6601178, ppf.org/pp), a Maryland charitable trust with federal tax-exempt status as a public charity under Section 501(c)(3) of the Internal Revenue Code.


Privacy Policy: ​You can read our Privacy Policy here
Terms of Use: You can read our Terms of Use here

Connect

  • LinkedIn
  • Facebook
  • Twitter
  • YouTube

Contact us

Please use our contact form.

bottom of page